• Mashup Score: 0

    Background: Bronchiectasis in adults with chronic obstructive pulmonary disease (COPD) is associated with greater mortality. However, whether suspected bronchiectasis—defined as incidental bronchiectasis on computed tomography (CT) images plus clinical manifestation—is associated with increased mortality in adults with a history of smoking with normal spirometry and preserved ratio impaired spirometry (PRISm) is unknown. Objective: To determine the association between suspected bronchiectasis and mortality in adults with normal spirometry, PRISm, and obstructive spirometry. Design: Prospective, observational cohort. Setting: The COPDGene (Genetic Epidemiology of Chronic Obstructive Pulmonary Disease) study. Participants: 7662 non-Hispanic Black or White adults, aged 45 to 80 years, with 10 or more pack-years of smoking history. Participants who were former and current smokers were stratified into normal spirometry (n = 3277), PRISm (n = 986), and obstructive spirometry (n = 3399). Meas

    Tweet Tweets with this article
    • New research reveals startling insights about impact of suspected bronchiectasis in adults w/ history of #smoking. Findings underscore importance of considering bronchiectasis, even in those w/ normal spirometry. https://t.co/peJqYvzwuX https://t.co/apdrfCmvC5

  • Mashup Score: 0

    Background Although non-pharmacological smoking cessation measures have been widely used among smokers, current research evidence on the effects of smoking cessation is inconsistent and of mixed quality. Moreover, there is a lack of comprehensive evidence synthesis. This study seeks to systematically identify, describe, and evaluate the available evidence for non-pharmacological interventions in smoking populations through evidence mapping (EM), and to search for best-practice smoking cessation programs. Methods A comprehensive search for relevant studies published from the establishment of the library to January 8, 2023, was conducted in PubMed, Web of Science, Embase, the Cochrane Library, CNKI, CBM, Wan Fang, and VIP. Two authors independently assessed eligibility and extracted data. The PRISMA statement and AMSTAR 2 tool were used to evaluate the report quality and methodology quality of systematic reviews/meta-analyses (SRs/MAs), respectively. Bubble plots were utilized to display

    Tweet Tweets with this article
    • Tao Nian et al. provide an overview of evidence behind non-pharmacological interventions for #smoking cessation: https://t.co/w1BipaQ0py #systematicreview #metaanalysis https://t.co/vqnlUfsrvk

  • Mashup Score: 3
    Risk Factors: Tobacco - 8 month(s) ago

    Tobacco use is a leading cause of cancer and of death from cancer. Find resources on the harms of tobacco use and how to get help quitting.

    Tweet Tweets with this article
    • #Smoking causes more deaths each year than the following causes combined: - HIV - Illegal drug use - Alcohol use - Motor vehicle injuries - Firearm-related incidents Learn more about the health effects of #cigarettes: https://t.co/QXlG5PcRRn https://t.co/7kvHRy6mJC

  • Mashup Score: 0

    Among various smoking cessation therapies, the highest likelihood for quitting was found with use of e-cigarettes, varenicline or cytisine, according to results published in Cochrane Database of Systematic Reviews.Cigarette smokers also had similarly improved chances of quitting with use of a nicotine patch paired with a fast-acting form of nicotine replacement therapy (NRT), according to

    Tweet Tweets with this article
    • 🗨️“This review provides further justification for both #varenicline and #cytisine to become more widely available as soon as possible,” @DrNLindson, PhD, CPsychol, at the @UniofOxford, told Healio. #smoking #cessation @CochraneTAG https://t.co/m2Xb7rgY4Y